KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Shares Issued: 2017-2024

Historic Shares Issued for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to $732,000.

  • Aquestive Therapeutics' Shares Issued rose 53.37% to $296,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 39.82%. This contributed to the annual value of $732,000 for FY2024, which is 1776.92% up from last year.
  • Per Aquestive Therapeutics' latest filing, its Shares Issued stood at $732,000 for FY2024, which was up 1,776.92% from $39,000 recorded in FY2023.
  • In the past 5 years, Aquestive Therapeutics' Shares Issued ranged from a high of $6.2 million in FY2020 and a low of $34,000 during FY2022.
  • Its 3-year average for Shares Issued is $268,333, with a median of $39,000 in 2023.
  • Its Shares Issued has fluctuated over the past 5 years, first slumped by 97.02% in 2021, then spiked by 1,776.92% in 2024.
  • Yearly analysis of 5 years shows Aquestive Therapeutics' Shares Issued stood at $6.2 million in 2020, then slumped by 97.02% to $185,000 in 2021, then plummeted by 81.62% to $34,000 in 2022, then grew by 14.71% to $39,000 in 2023, then spiked by 1,776.92% to $732,000 in 2024.